Manuscript citation: Bhatia S. Pitfalls found in SARS CoV-2 specific test performance during the comparison between WHO recommended method and a commercial test. Atlantic J Med Sci Res 2023;3(1):22-6. Doi:10.5455/atjmed.2022.12.024
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: May 31, 2024
Last Modified: May 31, 2024
Protocol Integer ID: 100988
Keywords: SARS CoV-2, real time PCR, Coronavirus, pandemic outbreak, Wuhan strain, Omicron mutation, multiplex assay lack the sensitivity, mutation resistant real time pcr, multiplex assay, multiplex assay lack, mutation resistant test, such multiplex assay, different genes of the virus, pcr kit for the detection, singleplex assay, reliable results because the mutation, performance of other test, singleplex test, mutated versions like south african mutation, resistant real time pcr, uk mutation, performance against many test, resistant test, pcr kit, indian mutation, mutation, different gene, south african mutation, sar, real time pcr, different laboratory, zikavirus, pcr, mutated version, many test, other test, beginning of the pandemic outbreak, omicron mutation, virus, different laboratories in the world, time pcr